Expression of BRM was also found silenced in cell lines derived from multiple tumor types through an epigenetic mechanism and restoration of its expression by HDAC (histone deacetylases) inhibitors was considered as an approach in cancer therapy [17]. This evidence concerns the gene SMARCA2 and neoplasm.